Editorial

DOI: 10.4244/EIJ-E-24-00052

Low-flow, low-gradient aortic stenosis: an understanding is still a long way off

John Webb1,2, MD; Sophie Offen1,2, MBBS, PhD

Low-gradient (LG) aortic stenosis (AS) is estimated to account for at least one-third of all presentations in patients with suspected severe AS. Even though frequently encountered in clinical practice, patients with LG-AS are less likely to be referred for aortic valve replacement (AVR) compared to those with high-gradient (HG) AS, despite evidence to suggest a survival benefit with AVR over conservative management1. At least part of this therapeutic inertia is no doubt secondary to the ongoing diagnostic challenge associated with the correct adjudication of stenosis severity in patients presenting with discordant markers of AS severity on initial transthoracic echocardiography. Current society guidelines advocate a stepwise integrated approach for the diagnosis of LG-AS, utilising dobutamine stress echocardiography (DSE) and/or computed tomography calcium score, in patients with an aortic valve area <1 cm2 and a mean gradient <40 mmHg2. These additional diagnostic modalities are intended to classify patients into 1 of 2 dominant patterns in LG-AS: classical low-flow, LG-AS (cLFLG-AS), in patients with a depressed left ventricular ejection fraction (LVEF; <50%), and paradoxical LFLG-AS (pLFLG-AS), in those with a normal...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 22
Nov 18, 2024
Volume 20 Number 22
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10I7A134 Nov 20, 2014
Low-flow, low-gradient aortic stenosis: should TAVI be the default therapeutic option?
O’Sullivan C and Wenaweser P
free

10.4244/EIJV10SUA8 Sep 27, 2014
Assessment of low-flow, low-gradient aortic stenosis: multimodality imaging is the key to success
Clavel M-A and Pibarot P
free

Original Research

10.4244/EIJ-D-24-00442 Nov 18, 2024
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis
Cardaioli F et al

Debate

10.4244/EIJ-E-22-00039 Nov 18, 2022
TAVI in moderate aortic stenosis and heart failure: pros and cons
Delgado V et al
free

Editorial

10.4244/EIJ-E-23-00054 Dec 4, 2023
Cardiac damage staging in the flow-gradient patterns of aortic stenosis
Pibarot P and Tastet L
free
Trending articles
225.68

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
105.78

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.85

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
68.7

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
45.3

Clinical research

10.4244/EIJ-D-18-01126 Aug 29, 2019
New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot K et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved